Understanding Graft-versus-Host Disease After Blood Cancer Transplant

For many blood cancer patients, a stem cell or bone marrow transplant represents one of the most hopeful turning points in treatment — the chance for a cure or long-term remission. But the weeks and months after transplant bring their own set of challenges, and one of the most significant is graft-versus-host disease, commonly known as GvHD. Understanding what GvHD is, what it looks like, and how it is managed can help patients and families feel more prepared for the road ahead.

GvHD is one of the most common complications following an allogeneic stem cell transplant — the type where donor cells are used rather than the patient's own. Research estimates that roughly 35 to 50 percent of allogeneic transplant recipients will develop some form of GvHD, making it an experience that many transplant patients and their caregivers will need to navigate.

What Is Graft-versus-Host Disease?

In an allogeneic transplant, a patient receives stem cells from a donor — often a sibling, an unrelated match, or a cord blood unit. These donor cells rebuild the patient's immune system, which is essential for recovery. However, the new immune cells can sometimes recognize the patient's own tissues as foreign and mount an attack against them. When the donated cells (the "graft") attack the patient's body (the "host"), the result is graft-versus-host disease.

GvHD does not occur with autologous transplants, where the patient's own stem cells are collected and returned after high-dose treatment. It is specifically a complication of receiving someone else's cells. While doctors take careful steps to match donors and use medications to help prevent GvHD, it remains a significant risk that patients should be aware of before and after transplant.

Acute vs. Chronic GvHD: Two Different Conditions

GvHD is broadly classified into two forms — acute and chronic — and understanding the difference matters because they affect the body in distinct ways and require different management approaches.

Acute GvHD typically develops within the first 100 days after transplant, though it can appear later. It most commonly affects three organ systems: the skin, the gastrointestinal tract, and the liver. A skin rash — often starting on the palms, soles, or ears — is frequently the earliest sign. Gastrointestinal symptoms can include nausea, vomiting, diarrhea, and abdominal pain. Liver involvement may show up as jaundice or abnormal liver function tests.

Chronic GvHD usually develops after day 100, though it can overlap with or follow acute GvHD. It tends to affect a broader range of organs and tissues, including the skin, eyes, mouth, lungs, joints, muscles, and the digestive system. Chronic GvHD often resembles autoimmune conditions like scleroderma or Sjögren's syndrome, with symptoms such as skin tightening, dry eyes, dry mouth, shortness of breath, and joint stiffness. It can range from mild to severe and may last months or even years.

Symptoms to Watch For After Transplant

Early detection of GvHD makes a meaningful difference in how effectively it can be managed. Patients and caregivers should be vigilant about changes in the body after transplant, especially in the weeks and months following discharge. Symptoms to monitor include:

• Skin changes — rash, redness, blistering, thickening, tightening, or discoloration
• Digestive issues — persistent nausea, vomiting, diarrhea, abdominal cramping, or unexplained weight loss
• Eye and mouth dryness — gritty or burning eyes, sensitivity to light, dry mouth, white patches inside the mouth, or difficulty swallowing
• Liver signs — yellowing of the skin or eyes, dark urine, or unusual fatigue
• Respiratory symptoms — shortness of breath, persistent cough, or wheezing
• Musculoskeletal changes — joint stiffness, muscle weakness, or limited range of motion

How Graft-versus-Host Disease Is Treated

Treatment for GvHD focuses on two goals: managing symptoms and preventing further organ damage. The approach depends on which organs are involved and how severe the condition is.

For mild cases limited to a single area — such as a skin rash — treatment may involve topical therapies like steroid ointments or steroid eye drops for ocular GvHD. When GvHD is more widespread or severe, systemic immunosuppressive medications, most commonly corticosteroids, form the foundation of treatment. Additional immunosuppressive drugs may be added if the initial response is insufficient.

Supportive care is just as important as medication. Physical therapy, occupational therapy, and pelvic floor therapy can help maintain mobility and function. Specialized eye care, dental care, and nutrition support may also be part of a comprehensive GvHD management plan. Your transplant team will typically coordinate a multidisciplinary approach tailored to the specific organs affected.

Living with GvHD: Practical Tips for Daily Life

GvHD can affect daily routines in ways that are both physical and emotional. Patients who have navigated it often share a few practical strategies that help:

• Take medications exactly as prescribed. GvHD medications often involve a carefully managed tapering schedule. Stopping or adjusting doses without guidance from your transplant team can cause flare-ups.
• Protect your skin. Use gentle, fragrance-free moisturizers daily. Wear sun-protective clothing and sunscreen — GvHD-affected skin is especially sensitive to UV damage.
• Stay hydrated and nourish your body. If mouth sores or swallowing difficulty make eating challenging, work with a dietitian to find tolerable foods and supplements that maintain your nutrition.
• Keep moving when you can. Gentle exercise and stretching help maintain joint flexibility and muscle strength, especially for patients with chronic GvHD affecting the skin or joints. Ask your team about a physical therapy referral.
• Monitor and communicate. Keep a simple symptom journal noting any changes in your skin, eyes, mouth, digestion, or energy level. This gives your care team valuable information at follow-up appointments.

The Emotional Weight of GvHD

After the intensity of transplant, many patients expect recovery to feel like a steady climb forward. When GvHD develops, it can feel like a setback — physically and emotionally. Frustration, anxiety, grief over changes in appearance or ability, and the exhaustion of managing a chronic condition on top of cancer recovery are all common and valid responses.

Finding an outlet to express what you are feeling — whether through a support group, a counselor, a trusted friend, or a journal — can reduce stress and help you move forward in a healthy way. Organizations like the National Marrow Donor Program offer free, confidential counseling for transplant patients and their families. Engaging in activities that remind you of who you are beyond your diagnosis — hobbies, creative projects, time with loved ones — can also restore a sense of normalcy during a difficult chapter.

Caregivers navigating GvHD alongside a loved one also deserve support. Emotional burnout is common after long stretches of caregiving, and seeking help early — before distress affects your own health — is not a sign of weakness. It is an essential part of sustaining the care your loved one needs.

Questions to Ask Your Transplant Team

Whether you are preparing for a transplant or already managing GvHD symptoms, these questions can help guide productive conversations with your care team:

1. What is my risk of developing GvHD based on my donor match and conditioning regimen?
2. What medications am I taking to help prevent GvHD, and for how long?
3. What symptoms should prompt me to call the clinic right away versus waiting for my next appointment?
4. Are there clinical trials for GvHD prevention or treatment that I might be eligible for?
5. What supportive therapies — physical therapy, nutrition counseling, eye care — should I be using alongside my GvHD treatment?
6. How will GvHD management affect my other medications and my overall recovery timeline?

Removing Barriers During Recovery

Recovery from a stem cell transplant — with or without GvHD — often means months of frequent clinic visits, restricted activity, and an extended time away from work. During that stretch, the everyday expenses that do not pause for a medical crisis — rent, utilities, groceries, transportation to appointments — can become overwhelming.

The Live Like Brent Foundation Comfort Fund helps blood cancer patients overcome non-medical barriers to treatment by paying approved expenses directly to the company or organization providing the service — things like utility bills, rent, transportation to treatment, lodging near the hospital, and food support. When those burdens are lifted, patients and families can focus their energy on healing.

If you or someone you love is navigating life after a blood cancer transplant, your support helps remove the barriers that stand between patients and the care they need.